(First published on Linkedin)
In corporate governance, related party transactions (RPTs) are a double-edged sword. They can be essential for operational efficiency, yet they carry the potential for conflicts of interest that, if not managed properly, can undermine shareholder value and erode trust in the company. RPTs are a nuanced aspect, often walking the fine line between strategic synergy and perceived impropriety.
The recent scrutiny by regulators, especially in case of multinationals, on these transactions has highlighted the fine line between the two. This begs a question: Do these transactions carry the aroma of strategic value, or do they now risk being overshadowed by the stink of regulatory overreach?
Background: RPTs, by their very nature, involve dealings between a company and its affiliates – whether through ownership, management, or familial ties. These transactions can be crucial for business continuity and operational efficiency. However, recent regulatory scrutiny has sparked debate.
Key Takeaways:
1. Commercial Perspective: RPTs often provide companies with a way to streamline operations, optimize resources, and leverage synergies within a corporate group. However, the commercial rationale behind these transactions needs to be well-documented and transparent to avoid being caught in the crossfire of regulatory scrutiny. Overzealous enforcement could dissuade companies from engaging in beneficial RPTs, ultimately stifling business growth.
2. Regulatory Perspective: Recent regulatory actions, particularly in high-profile cases, have sparked concerns of regulatory overreach. This ensures that companies cannot bypass shareholder approval requirements through technical loopholes. However, this approach could also mean that the regulators are excessively interventionist, potentially impeding legitimate commercial activities that do not necessarily pose a risk to shareholders.
3. Tax Implications: Tax authorities have always scrutinized RPTs to ensure they are conducted at arm’s length. The increased regulatory focus on these transactions could lead to heightened tax scrutiny as well, potentially complicating compliance and increasing the administrative burden on companies, especially when it involves cross border transactions and transfer pricing implications. The complexities of GST on RPTs further complicate the landscape. Transactions between related parties, even those not involving cash consideration, can attract GST. Regulatory overreach in this domain could result in companies facing additional tax liabilities, which may not have been intended under normal commercial operations.
The balance between oversight and overreach is delicate, and it’s crucial that regulatory actions do not inadvertently turn the aroma of strategic value into the stink of overregulation.